| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6299745316457389 3.8368049285376977 0.0001246454028072 0.0716006366463556 0.0371443300365491 54 Q9UDW1,O75880,O14949,Q7KZN9,O75964,P13073,P14406,P24539,P14927,O95169,P21912,O96000,P00846,P20674,P22695,Q9Y6M9,P56385,P00403,O95168 19 |
| Nonalcoholic fatty liver disease 0.5715201480308567 3.2098847362463916 0.0013278820839381 0.54703645998628 0.113059674575309 51 P13073,P14406,P20674,O95169,Q96GC9,Q86Y39,P22695,Q9P0J0,Q9Y6M9,Q9UDW1,P21912,O96000,O14949,P00403 14 |
| Mitochondrial complex iv assembly 0.7970796572125457 2.963683991669388 0.0030398027580069 0.8370776669870535 0.1878700119576529 13 P13073,P20674,P14406,Q9Y6N1,Q9Y2R0,Q96I36,O43819,Q7KZN9,P00403 9 |
| Mitochondrial complex i assembly model oxphos system 0.6055438886913772 2.8135418968195745 0.0048999000507912 0.9464702966376556 0.204812486767911 28 Q9BQ95,O95169,Q9BUB7,Q9P0J0,Q96CU9,Q9Y6M9,O96000,Q9NPL8,Q9NX14,O95168,Q8IUX1 11 |
| Mitochondrial complex iii assembly 0.8289672444502935 2.806016179918169 0.0050158173675312 0.9500608255851334 0.204812486767911 10 P14927,Q9Y276,P22695,Q9UDW1,O14949 5 |
| Oxidative phosphorylation 0.5463290968526939 2.586896041824243 0.0096844805713574 0.9969726915697442 0.204812486767911 33 P24539,O95169,Q86Y39,P06576,Q9Y6M9,O96000,O95168,P56385,P00846,O75964,Q15904 11 |
| Kennedy pathway from sphingolipids 0.912555436577804 2.48148481155925 0.0130836286091398 0.9996099766896052 0.204812486767911 5 Q9BVG9,O95470,P35790 3 |
| Ferroptosis 0.5832822630551003 2.469221728399054 0.0135407287659401 0.999704077019426 0.204812486767911 24 P04035,P02792,P08195,P16435,P45880,Q15043,Q15758,Q9NZ45,P09601,Q9Y277,P02786,P37268 12 |
| Sphingolipid metabolism in senescence 0.7583918310901185 2.454974720707213 0.0140894495930945 0.9997875980961844 0.204812486767911 10 O15269,P04062,P16278,Q13510 4 |
| Ccl18 signaling pathway 0.7169500082871361 2.357200099331466 0.0184133218054838 0.9999845304114536 0.2275606687500745 11 P08670,P07196,P00403,Q86UE4 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.7066998327745971 2.302295108506199 0.0213185354940714 0.9999973560547484 0.2405180941729724 11 Q9NR77,Q8TB36,P07196,O95140,P04792,Q15907,Q9UI14 7 |
| Mitochondrial immune response to sarscov2 0.7620072335799413 2.2592931673125105 0.0238651546590964 0.9999994404351328 0.2495374066109031 8 Q9BQ95,Q99623,Q9Y6M9,Q9Y276 4 |
| Glycosaminoglycan degradation 0.8199280837256331 2.2218195037013286 0.026295506106708 0.9999998733526996 0.2542951164920201 6 P06865,P16278,P15586,P54802 4 |
| Sphingolipid metabolism overview 0.8120824518361381 2.186676056849438 0.0287661806972048 0.9999999721398952 0.2542951164920201 6 O15269,O95470,Q13510 3 |
| Sphingolipid metabolism integrated pathway 0.8120824518361381 2.186676056849438 0.0287661806972048 0.9999999721398952 0.2542951164920201 6 O15269,O95470,Q13510 3 |
| Degradation pathway of sphingolipids including diseases 0.8063583815028732 2.1609468904543543 0.030699442184493 0.999999991503428 0.2637240536326816 6 P06280,P17900,O43681,P16278,P06865 5 |
| Oxidation by cytochrome p450 0.8032446790009128 2.146919597574959 0.0317996831311278 0.999999995682112 0.2644595387614276 6 Q6UW02,O43169,Q16850 3 |
| Proteoglycan biosynthesis 0.90982028241334 2.145058972516934 0.031948132199367 0.9999999960592232 0.2644595387614276 4 Q8TB61,Q8NCH0,Q9NX62 3 |
| Statin inhibition of cholesterol production 0.821200358634524 2.0901097163450113 0.0366079450639362 0.9999999997778616 0.2720549548772797 5 P37268,Q8WTV0,Q14534 3 |
| Endothelin pathways 0.7258285779342764 2.0818151937314737 0.0373593533961544 0.9999999998604724 0.2720549548772797 8 P42892,P00403 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5262619015208952 2.081038527721426 0.0374303796978807 0.9999999998664753 0.2720549548772797 25 Q14534,Q16850,Q15800,O95749,Q15392,Q9BWD1,P37268,O75845 8 |
| Familial partial lipodystrophy fpld 0.7059731463632821 1.982854391096066 0.0473836964462957 0.9999999999997276 0.3103371767251894 8 P20700,O60725,Q03252,P02545,O75844,P49354 6 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7865168539325855 1.937061446270004 0.0527378326732197 0.9999999999999906 0.3416494377525975 5 O60725,P20700,P02545,Q03252 4 |
| Copper homeostasis 0.6749274532827882 1.918477696313592 0.0550504675501535 0.9999999999999978 0.3475820781272767 9 Q04656,Q9Y6N1,O75880,P35670,O43819 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7402923939090129 1.858616160236503 0.0630815648257752 1.0 0.3709454242912344 6 Q15392,Q15738,Q16850,O75845 4 |
| Sphingolipid pathway 0.7034242019307837 1.7983060226621066 0.0721285258642745 1.0 0.4017626300477348 7 O15269,O95470,Q13510,P04062 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.551284080797398 1.7870424630907027 0.0739306257293428 1.0 0.4024382945751545 16 O60725,Q9Y2U8,P02545,P42167,P55209,O75844,P50402,P49354,P25054 9 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8181020316578906 1.7639716507599308 0.0777367522452436 1.0 0.4136705744479038 4 P09601 1 |
| Metapathway biotransformation phase i and ii 0.4921429943316818 1.7232769096579548 0.0848384613019597 1.0 0.4384304635450994 22 Q8NCH0,Q6UW02,Q7LGA3,P21964 4 |
| Mitochondrial long chain fatty acid betaoxidation 0.5612089143013775 1.7000665882957136 0.08911840109044 1.0 0.4426213920825187 14 O43772,P23786,P50416 3 |
| S1p receptor signal transduction 0.6479202612188045 1.6873363535627977 0.091538694509657 1.0 0.4471890321947178 8 P04899,P31751,P27361,Q13510 4 |
| Glycosylation and related congenital defects 0.6395221482239484 1.6438563185143134 0.1002058848778455 1.0 0.4726124711856482 8 Q9BV10,Q9H6U8,Q9BT22 3 |
| 1q211 copy number variation syndrome 0.6061183992091733 1.6437332554652329 0.1002313134852432 1.0 0.4726124711856482 10 Q9NPH0 1 |
| Progeriaassociated lipodystrophy 0.5924353008257021 1.5673054600256475 0.1170433097576479 1.0 0.5129250927614574 10 P20700,O60725,Q03252,P02545,O75844 5 |
| Vitamin d receptor pathway 0.5564134166814352 1.4558280172261613 0.1454401685819617 1.0 0.5665512449336549 11 P08183,Q96KA5,P20020,Q5VV42 4 |
| Cholesterol biosynthesis pathway 0.5207541669892761 1.4426997791311924 0.1491050614947968 1.0 0.5748389839890989 14 P04035,Q14534,Q15738,Q16850,Q15800,P14324,P37268,O75845 8 |
| Nephrotic syndrome 0.5321863026050766 1.441311444067627 0.1494967156347488 1.0 0.5748389839890989 13 O75844,Q14108 2 |
| Amyotrophic lateral sclerosis als 0.58337137036202 1.428602311499524 0.1531185694174826 1.0 0.5812653972791059 9 P07196,Q9BUN8,O96008 3 |
| Adipogenesis 0.5019471825943727 1.398496014696771 0.161964168597084 1.0 0.598399310109997 15 O75844,Q9NZ45 2 |
| Allograft rejection 0.5755850048531559 1.3859751571384362 0.1657544894436022 1.0 0.5994506844273038 9 P08183,P10321,P08670 3 |
| Relationship between inflammation cox2 and egfr 0.7282326615868759 1.3798135368197426 0.1676440635911433 1.0 0.5994506844273038 4 P31751,Q9H7Z7 2 |
| Striated muscle contraction pathway 0.6576274407199625 1.3495999191075976 0.17714435014389 1.0 0.6064732914318653 5 P08670,P67936,P09493 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.8719923002887319 1.3356719922535196 0.1816565076915592 1.0 0.6114844405754853 3 O95470,Q10472 2 |
| Influence of laminopathies on wnt signaling 0.5335326707621764 1.3207663332122497 0.186579288577704 1.0 0.6114844405754853 11 O60725,Q5JTV8,P02545,O75844,P50402,P49354 6 |
| Cellular proteostasis 0.6419778947232611 1.276807930595658 0.2016700649847322 1.0 0.6359542789994732 5 O15212,Q9UHV9 2 |
| Vitamin d metabolism 0.8508359857509991 1.2529494047958507 0.210224120354074 1.0 0.6509370477798814 3 P38435 1 |
| Alzheimers disease and mirna effects 0.3617737433143113 1.2310747043145438 0.2182949253816717 1.0 0.6509370477798814 82 P28074,P49721,P16615,Q13885,Q9BVA1,Q9NQC3,P07437,Q96GC9,P45880,Q92542,Q9Y277,P21796,Q96IX5,O95197,P68371 15 |
| Glycerolipids and glycerophospholipids 0.6069692199922665 1.2222196203316789 0.2216245861291712 1.0 0.6509370477798814 6 Q9BVG9 1 |
| Eicosanoid synthesis 0.8527902501603638 1.188578746385987 0.234605475449865 1.0 0.6626770775740262 2 Q9H7Z7 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.4803619981754791 1.1805346811442523 0.2377876252710633 1.0 0.6684972861394045 14 P16615,Q14118,P50402,P02545 4 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.681200283217136 1.1766739716874832 0.2393256604954818 1.0 0.6696624115272638 4 Q07820 1 |
| Ketogenesis and ketolysis 0.5694252951624977 1.1302318790477155 0.2583785301503587 1.0 0.6968036378715556 7 P23786 1 |
| Glycerophospholipid biosynthetic pathway 0.5673063673398836 1.119462751614815 0.2629427730776525 1.0 0.6985428368081307 7 Q86UL3,O95674,O00116 3 |
| Omega3 omega6 fatty acid synthesis 0.581029252436512 1.095885297003672 0.27312897420425 1.0 0.7017986080893664 6 O15254,P33121,Q15067 3 |
| Zinc homeostasis 0.8079234235637653 1.0859920612796896 0.2774825045312377 1.0 0.7026097267745854 3 Q8TAD4 1 |
| Triacylglyceride synthesis 0.639259630261259 0.9961826983646352 0.3191613842861924 1.0 0.7238072902921343 4 O00116 1 |
| Alzheimers disease 0.340871042156129 0.9950804568021528 0.3196971348555961 1.0 0.7238072902921343 80 P28074,P49721,Q9NSK0,Q9Y277,P21796,P16615,P45880,Q92542,P04350,O95197,P12235,Q9NQC3,P07437,O00459,Q8NE86,P12236,Q13885,Q9BVA1,Q9BUF5,P68371 20 |
| Apoptosis modulation and signaling 0.4770211740437888 0.9831216000944082 0.3255475945995558 1.0 0.7294224300050198 11 O43464,P27361,Q9NR28,Q9Y3E5,O95831,Q07820 6 |
| Nanomaterial induced apoptosis 0.6214617089021685 0.9202675067466096 0.3574329847340396 1.0 0.7635485982132172 4 Q9NR28,O95831 2 |
| Camkk2 pathway 0.4657012533166073 0.9152508312442056 0.3600599650025282 1.0 0.7636859044181737 11 P09601 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4800628833476318 0.8571358336587039 0.3913698194289488 1.0 0.801418709521071 9 P27361,P31943,O14964,P62070,P61020 5 |
| Proximal tubule transport 0.4781342829224588 0.8464714770229683 0.3972897791119001 1.0 0.801418709521071 9 P08183,P05023,P05026,P08195 4 |
| Apoptosis 0.4772166448651415 0.8413997529074022 0.4001240238627264 1.0 0.801418709521071 9 Q9NR28 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4520783441872882 0.8337288227890317 0.4044338123260516 1.0 0.801418709521071 11 Q5JRA6,O75718,P07237,Q32P28,P13674 5 |
| Mthfr deficiency 0.4868522280162597 0.8331797851948454 0.4047433415534267 1.0 0.801418709521071 8 P21964 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7597819114817176 0.8162295160362472 0.414368878362974 1.0 0.8090387543374479 2 P08195 1 |
| Congenital generalized lipodystrophy cgl 0.7588197562540075 0.8125208906153132 0.4164928043780116 1.0 0.8090387543374479 2 P31751 1 |
| Preimplantation embryo 0.5045432272991083 0.8010402118288722 0.4231083668124824 1.0 0.8121263167115497 7 Q99729,P05023 2 |
| Pparalpha pathway 0.4797028991132694 0.7951907028751105 0.4265025790783809 1.0 0.8121263167115497 8 P23786 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.7508017960230979 0.7817750862522995 0.4343467650823864 1.0 0.8131904542668805 2 P23634 1 |
| Vitamin dsensitive calcium signaling in depression 0.4955618424700792 0.7559184833569205 0.4496980713232128 1.0 0.8205605958685357 7 P20020,P23634 2 |
| Mevalonate pathway 0.5100694564148948 0.7525448800946203 0.4517234508801171 1.0 0.8205605958685357 6 Q9BWD1,P04035 2 |
| Phase i biotransformations non p450 0.7102634794170422 0.7182488071588415 0.4726038888773529 1.0 0.8300025520732648 3 Q15165 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5723937178106451 0.7152168533371758 0.4744750566689768 1.0 0.8300025520732648 4 P08670 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4047955520386966 0.5927228111056181 0.5533666727807129 1.0 0.8865767123045831 12 O95749,P37268,Q9BWD1 3 |
| Interleukin1 induced activation of nfkb 0.6828094932649114 0.5355475994952076 0.5922712521542817 1.0 0.9121283366510384 2 Q13501 1 |
| Lung fibrosis 0.4565827523768445 0.5042852008533916 0.6140609755652215 1.0 0.9172439635009324 6 P09601 1 |
| Fatty acid betaoxidation 0.3418145475130728 0.4661927807803894 0.6410775163225673 1.0 0.9404705034493994 19 O43772,P23786,P50416 3 |
| Ciliopathies 0.3528682187277882 0.463735753383226 0.6428370781379109 1.0 0.9404705034493994 17 Q10713 1 |
| Nad metabolism 0.4957086046231498 0.4190969219455412 0.6751453001439209 1.0 0.9404705034493994 4 P43490 1 |
| Fatty acid transporters 0.4894094993581548 0.3968333796183015 0.6914903340953762 1.0 0.94267201914541 4 O95573,P33121,O60488 3 |
| Nocgmppkg mediated neuroprotection 0.4153488271961952 0.3701993831301609 0.7112339361794155 1.0 0.9461951472386868 7 P07196 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4103421272130624 0.3477997344203555 0.727990589128358 1.0 0.9462416481682464 7 Q8IXH7 1 |
| Ppar signaling pathway 0.3384534575703582 0.3363921403023263 0.7365751756375267 1.0 0.9462416481682464 16 P23786,P50416 2 |
| Nanoparticle triggered autophagic cell death 0.4103123347804481 0.2647074164953913 0.7912348637106981 1.0 0.9545149152624094 5 Q96GC9 1 |
| Supression of hmgb1 mediated inflammation by thbd 0.5878768441308476 0.2579507936439993 0.7964448832783502 1.0 0.9545149152624094 2 Q9Y6K9 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.3169654196531268 0.2565003940910491 0.7975644761756373 1.0 0.9545149152624094 18 P08670,Q14108 2 |
| Bile acids synthesis and enterohepatic circulation 0.5540583894770704 0.2351465793245917 0.8140949669977318 1.0 0.963378801043856 3 P51114,P27361 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.329177793927639 0.2211412717766985 0.8249824354315078 1.0 0.9636173431349676 14 O43819,P43490 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4329362061305628 0.2174776790357253 0.827836100283432 1.0 0.9636173431349676 4 P18031,P06753 2 |
| Vasopressinregulated water reabsorption 0.311353393461825 0.1933517642639849 0.8466834890813617 1.0 0.9722993439161688 17 Q15907,Q13561 2 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.5538806927517598 0.1843783614990333 0.853716643825015 1.0 0.9783916941085306 2 Q9Y6K9 1 |
| Vitamin b12 disorders 0.5248636509464345 0.1708800940406681 0.8643180490913362 1.0 0.9783916941085306 3 Q99707,Q96EY8 2 |
| Cannabinoid receptor signaling 0.3730663569638899 0.1677714145929263 0.8667631115592351 1.0 0.9783916941085306 6 Q8NCG7 1 |
| Thermogenesis 0.2852763149934725 0.1444207609752688 0.8851682237751524 1.0 0.9890432919796354 27 P23786,P50416 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.5307889672867152 0.1431696000291778 0.886156238115982 1.0 0.9890432919796354 2 Q7Z434 1 |
| Purinergic signaling 0.3995507060333821 0.1320864560372428 0.8949159085621856 1.0 0.9913938317900792 4 P04899,P09471,P63096 3 |
| Tlr4 signaling and tolerance 0.3658216517384852 0.1239831481835839 0.9013286179065588 1.0 0.9925098379567526 5 Q15629 1 |
| Male infertility 0.2868889068017164 0.1231751205018859 0.90196842648588 1.0 0.9925098379567526 21 P08183,Q15165,Q15645,P50750 4 |
| Genes related to primary cilium development based on crispr 0.3148387065453583 0.1200376563813972 0.904453318131198 1.0 0.9925098379567526 13 Q10713 1 |
| Genes controlling nephrogenesis 0.3918485237484063 0.1148679665482727 0.9085497759793087 1.0 0.9935700302452624 4 O94813,P35222,P05556 3 |
| Praderwilli and angelman syndrome 0.3572119067386784 0.1007025409577075 0.9197865942377644 1.0 1.0 5 Q05086,Q15154 2 |
| Apoptosis modulation by hsp70 0.4823562909058034 0.0961415186421142 0.9234081769057848 1.0 1.0 3 O95831 1 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.4794740218088438 0.0764291636409041 0.9390776682261022 1.0 1.0 2 P00367 1 |
| Calcium regulation in cardiac cells 0.2761230001478817 0.056425019693436 0.9550032258691328 1.0 1.0 23 P05026,P16615,P04899,P20020,P23634 5 |
| Endometrial cancer 0.3000963023957719 0.0501828142222954 0.9599767065613178 1.0 1.0 13 P27361,O00459,P62993,P25054,P31751 5 |
| Extracellular vesiclemediated signaling in recipient cells 0.3546213093709917 0.0453357131457886 0.9638397217174396 1.0 1.0 4 Q9NWH9,P25054,P35222 3 |
| Mirnas involved in dna damage response 0.4377806286080761 0.044387922039375 0.964595188977075 1.0 1.0 2 P16104 1 |
| Robo4 and vegf signaling pathways crosstalk 0.435856318152655 0.0433074698090244 0.965456436764132 1.0 1.0 2 O94813 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.3311917764214652 0.0427814899605177 0.9658757193506412 1.0 1.0 7 P27348,O96013,P35221,P05556,Q13177,P35222 6 |
| Sars coronavirus and innate immunity 0.4153303399615112 0.0336037376443806 0.9731931417438906 1.0 1.0 2 Q7Z434 1 |
| Hepatitis b infection 0.2720251785846441 0.0300517405212248 0.9760257888139195 1.0 1.0 23 Q9Y277 1 |
| Folate metabolism 0.2884206481947338 0.013829712158585 0.9889658379234708 1.0 1.0 14 Q8WTV0,P00374 2 |
|
|
